Assessing Impact of Early Physiotherapy on Lymphatic Dysfunction in Head and Neck Cancer Survivorship

PHASE1Enrolling by invitationINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 12, 2023

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
Lymphedema of FaceHead and Neck Cancer
Interventions
COMBINATION_PRODUCT

Near-infrared fluorescence lymphatic imaging

All subjects will undergo lymphatic imaging at enrollment, 3, 6, and 12 months to assess the extent of dermal lymphatic backflow. Small amounts (0.1 mL) of a solution of indocyanine green (ICG) will be intradermally injected near the ear and along the jaw. Images of the lymphatics will be acquired by shining a dim light on the face and neck and acquiring the resulting fluorescent signal emanating from ICG-laden lymph. Images will be processed to calculate the area of the head and neck that show abnormal dermal lymphatic backflow.

DEVICE

advanced pneumatic compression therapy

The advanced pneumatic compression device (APCD) mimics manual lymphatic drainage, a light massage that stimulates lymphatic uptake and function and frequently prescribed for lymphedema therapy.

Trial Locations (1)

77030

The University of Texas Health Science Center at Houston, Houston

All Listed Sponsors
lead

The University of Texas Health Science Center, Houston

OTHER